Amit Hazan
Stock Analyst at Goldman Sachs
(2.08)
# 3,024
Out of 5,045 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $73.07 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $6.77 | -63.07% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.41 | +1,247.52% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $16.34 | -51.04% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $52.79 | +19.34% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $179.38 | +51.63% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $15.14 | +12.29% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $12.63 | +3,344.18% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $34.38 | +27.98% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $83.48 | -12.55% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $19.16 | +176.62% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $30.69 | +85.73% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $16.33 | -41.82% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $124.67 | -16.58% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $12.44 | +382.32% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $90.97 | +26.42% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $368.98 | -59.35% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $100.57 | -54.26% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $530.02 | -54.40% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $99.56 | +77.78% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $189.05 | -22.24% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.38 | +182.61% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $73.07
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $6.77
Upside: -63.07%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.41
Upside: +1,247.52%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $16.34
Upside: -51.04%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $52.79
Upside: +19.34%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $179.38
Upside: +51.63%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $15.14
Upside: +12.29%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $12.63
Upside: +3,344.18%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $34.38
Upside: +27.98%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $83.48
Upside: -12.55%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $19.16
Upside: +176.62%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $30.69
Upside: +85.73%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $16.33
Upside: -41.82%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $124.67
Upside: -16.58%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $12.44
Upside: +382.32%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $90.97
Upside: +26.42%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $368.98
Upside: -59.35%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $100.57
Upside: -54.26%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $530.02
Upside: -54.40%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $99.56
Upside: +77.78%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $189.05
Upside: -22.24%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.38
Upside: +182.61%